Drug Type Fusion protein |
Synonyms glucagon-like peptide-2(PhaseBio) |
Target |
Action agonists |
Mechanism GLP-2R agonists(Glucagon-like peptide 2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Preclinical | United States | - | |
Mucositis | Preclinical | United States | - | |
Short Bowel Syndrome | Preclinical | United States | - |